TCGA-PANGI Samples Report
2018_12_25 Data Snapshot
- Overview
+ Introduction
- Summary

There were 0 redactions, 0 replicate aliquots, 0 blacklisted aliquots, and 0 FFPE aliquots. The table below represents the sample counts for those samples that were ingested into firehose after filtering out redactions, replicates, and blacklisted data, and segregating FFPEs.

Table 1.  This table provides a breakdown of sample counts on a per sample type and, if applicable, per subtype basis. Each count is a link to a table containing a list of the samples that comprise that count and details pertaining to each individual sample (e.g. platform, sequencing center, etc.). Please note, there are usually multiple protocols per data type, so there are typically many more rows than the count implies.

Sample.Type BCR Clinical CN mRNA miR MAF Methylation
FFPE 13 13 12 13 7 12 12
NB 1002 998 1002 0 0 0 0
TR 2 2 2 2 2 2 1
TP 1261 1257 1243 1158 1225 1214 1251
TM 2 2 2 2 2 2 2
NT 273 273 266 94 65 0 130
Totals 1261 1257 1243 1158 1225 1214 1251

The sample type short letter codes in the table above are defined in the following list.

  • TP: Primary Tumor

  • TR: Recurrent Tumor

  • TB: Primary Blood Derived Cancer - Peripheral Blood

  • TRBM: Recurrent Blood Derived Cancer - Bone Marrow

  • TAP: Additional - New Primary

  • TM: Metastatic

  • TAM: Additional Metastatic

  • THOC: Human Tumor Original Cells

  • TBM: Primary Blood Derived Cancer - Bone Marrow

  • NB: Blood Derived Normal

  • NT: Solid Tissue Normal

  • NBC: Buccal Cell Normal

  • NEBV: EBV Immortalized Normal

  • NBM: Bone Marrow Normal

  • CELLC: Control Analyte

  • TRB: Recurrent Blood Derived Cancer - Peripheral Blood

  • CELL: Cell Lines

  • XP: Primary Xenograft Tissue

  • XCL: Cell Line Derived Xenograft Tissue

Figure 1.  Get High-res Image This figure depicts the distribution of available data on a per participant basis.

- Results
+ Methods & Data